Journal
Cell Metabolism
Publication Date
6-6-2023
Volume
35
Issue
6
First Page
928
Last Page
942.e4
Document Type
Open Access Publication
DOI
10.1016/j.cmet.2023.02.006
Rights and Permissions
Ozcan M, Guo Z, Valenzuela Ripoll C, Diab A, Picataggi A, Rawnsley D, Lotfinaghsh A, Bergom C, Szymanski J, Hwang D, Asnani A, Kosiborod M, Zheng J, Hayashi RJ, Woodard PK, Kovacs A, Margulies KB, Schilling J, Razani B, Diwan A, Javaheri A. Sustained alternate-day fasting potentiates doxorubicin cardiotoxicity. Cell Metab. 2023 Jun 6;35(6):928-942.e4. doi: 10.1016/j.cmet.2023.02.006. Copyright 2023 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Recommended Citation
Ozcan, Mualla; Guo, Zhen; Valenzuela Ripoll, Carla; Diab, Ahmed; Picataggi, Antonino; Rawnsley, David; Lotfinaghsh, Aynaz; Bergom, Carmen; Szymanski, Jeff; Hwang, Daniel; Zheng, Jie; Hayashi, Robert J; Woodard, Pamela K; Kovacs, Attila; Schilling, Joel; Razani, Babak; Diwan, Abhinav; Javaheri, Ali; and et al., "Sustained alternate-day fasting potentiates doxorubicin cardiotoxicity." Cell Metabolism. 35, 6. 928 - 942.e4. (2023).
https://digitalcommons.wustl.edu/oa_4/2606
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
